Teicoplanin IV infusion 400mg “Meiji” is a glycopeptide antibiotic manufactured by Meiji Seika Pharma Co., Ltd. It works by inhibiting bacterial cell wall synthesis and is indicated for conditions such as sepsis and pneumonia. This intravenous infusion is provided as 400mg per bottle, with YJ code 6119401D2058.
Teicoplanin IV infusion 400mg “Meiji”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →